Category Archives: AZBio News
C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases
TUCSON, Ariz., Sept. 14, 2022 — Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership (PPP) to benefit people across multiple rare neurodegenerative diseases, supported by a grant from the U.S. Food and Drug Administration (FDA). The Agency announced the PPP today in a press release.Continue reading
Aqualung Therapeutics Receives the AZBio Fast Lane Award and Achieves Key FDA-Related Milestones
Aqualung Therapeutics, an immunotherapeutics biotech company with an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced the achievement of two key FDA milestones for their therapeutic mAb ALT-100. First is the successful FDA IND submission for the indication of Acute Respiratory Distress Syndrome (ARDS). Second is the scheduling of an FDA Pre-IND type B meeting (September 14th) to discuss the targeted use of ALT-100 mAb in Radiation-induced Lung Injury and Fibrosis.Continue reading
Arizona Bioscience Week Career Pathways Program Reaches Classrooms Statewide
The Office of Maricopa County School Superintendent Steve Watson partnered with the Flinn Foundation to offer you and your classrooms opportunities to engage and learn from Arizona Life and Bioscience career professionals during Arizona Bioscience Week and in the Educator Pro Connect Platform.Continue reading
Castle Biosciences Honored with a 2022 AZBio Fast Lane Award from the Arizona Bioindustry Association
FRIENDSWOOD, Texas—Sept. 13, 2022–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received an AZBio Fast Lane Award from the Arizona Bioindustry Association (AZBio).Continue reading
ASU Named #1 for Innovation for Eighth Straight Year
For the eighth year in a row, Arizona State University is No. 1 in innovation in the newly released annual Best Colleges rankings by U.S. News & World Report.Continue reading
Catherine Ivy is being honored as the 2022 Arizona Bioscience Leader of the Year.
Catherine Ivy is an Arizona native and a woman on a mission. She became involved in the brain tumor community when her husband, Ben Ivy, lost his battle with glioblastoma brain cancer in 2005.Continue reading
UArizona Cancer Center again receives highest NCI designation as Comprehensive Cancer Center
The UArizona Cancer Center conducts novel research focused on developing new and better approaches to preventing, diagnosing and treating cancer. The center is the only one in Arizona with the highest designation awarded by the National Cancer Institute.Continue reading
ASU awarded lead of new National Science Foundation I-Corps Hub
Expansion of National Innovation Network to accelerate translation of research ideas to the marketplaceContinue reading
C-Path’s Kristen Swingle Named President
Swingle joined C-Path in 2019 and was named interim president in 2021
TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-Path) today announced that its Chief Operating Officer (COO) and Interim President, Kristen Swingle, M.S., has been named COO and President, effective immediately. Swingle has filled the interim President role since 2021, stewarding C-Path through growth and innovation, including the establishment of multiple national and global programs, a new European entity, a 50% staff increase, and a 90% increase in revenue.Continue reading